Top Story

Average vocal pitch decrease linked to testosterone dosing

April 17, 2015

Dose- and concentration-dependent decrease in average vocal pitch was found among women with higher levels of testosterone administration over 24 weeks, according to recent study findings published in The Journal of Clinical Endocrinology & Metabolism.

Grace Huang, MD, of Brigham and Women’s Hospital in Brookline, Massachusetts, and colleagues evaluated 71 women who underwent hysterectomy with or without oophorectomy with total testosterone less than 31 ng/dL and/or free testosterone less than 3.5 pg/mL to determine the dose-dependent effects of testosterone administration on voice changes in this population.

Rowan T. Chlebowski, MD, PhD In the Journals

Hormone therapy affects breast cancer risk differently over time

April 16, 2015
The risk for breast cancer associated with use of menopausal hormone therapy changes over time, according to an analysis of two Women’s Health Initiative clinical…
In the Journals

Withholding tamoxifen for 2 weeks prior to breast reconstruction may mitigate thrombotic risk

April 15, 2015
According to researchers, tamoxifen may have been overestimated previously as a microvascular thrombotic risk factor, with data suggesting that withholding the therapy…
In the Journals

GH therapy appears safe in children without risk factors for cancer

April 14, 2015
In children without known risk factors for developing cancer, the use of growth hormone therapy appears to be safe and does not confer an increased risk for subsequent…
CME
low no

Low- and No-Calorie Sweeteners in Weight Management: What Do You Need to Know?

This activity is supported by an educational grant from the American Beverage Association.

The use of low- and no-calorie sweeteners continues to grow as consumers continue to purchase foods and beverages…
More »
Meeting News Coverage Video
4131399993001 th

Video: Low kisspeptin could identify risk for miscarriage in asymptomatic women

June 21, 2014
Endocrine Today met with Ali Abbara, MBBS, BSc, MRCP, clinical research fellow at Imperial College London, United…
More »
CME
Obesity Consults: Volume 2, Number 3

Obesity Consults: Volume 2, Number 3
Biology and Behavior

This activity is supported by an educational grant from Vivus, Inc and Eisai Co., Ltd.

Obesity is a complex, multifactorial disease. Understanding how psychology, genetics, biology and neurobiology…
More »
In the Journals

Average vocal pitch decrease linked to testosterone dosing

April 17, 2015
Dose- and concentration-dependent decrease in average vocal pitch was found among women with higher levels of testosterone administration over 24…
Rowan T. Chlebowski, MD, PhD In the Journals

Hormone therapy affects breast cancer risk differently over time

April 16, 2015
The risk for breast cancer associated with use of menopausal hormone therapy changes over time, according to an analysis of two Women’s Health…
In the Journals

Withholding tamoxifen for 2 weeks prior to breast reconstruction may mitigate thrombotic risk

April 15, 2015
According to researchers, tamoxifen may have been overestimated previously as a microvascular thrombotic risk factor, with data suggesting that…
In the Journals

GH therapy appears safe in children without risk factors for cancer

April 14, 2015
In children without known risk factors for developing cancer, the use of growth hormone therapy appears to be safe and does not confer an increased…

Orphan drug shows promise in Prader-Willi syndrome

March 28, 2015
Ten weeks of therapy with a diazoxide choline controlled-release tablet appeared to help control hyperphagia and reduce antisocial behaviors…
In the Journals

HT may reduce mortality risk in statin-treated postmenopausal women

March 20, 2015
In women treated with statins, hormone therapy appears to decrease the risk for death from any cause, according to research published in…
In the Journals

Oral melatonin may benefit sleep-deprived ICU patients

March 20, 2015
Melatonin could offer more and better quality sleep compared with earplugs and eye masks after exposure to environments with high levels of noise and…
Henry Boardman In the Journals

Hormone therapy offers no CV protection for postmenopausal women, may increase stroke risk

March 13, 2015
Hormone replacement therapy does not protect postmenopausal women against cardiovascular disease and may increase their risk for stroke and venous…
Charles Tegeler In the Journals

Noninvasive neurotechnology relieves menopause-related symptoms

March 13, 2015
Women in midlife experienced decreases in menopause-related symptoms and temporal high-frequency brain electrical activity with a noninvasive…
Meeting News Coverage

Risk for venous thrombotic events no higher in men with hypogonadism on testosterone therapy

March 11, 2015
SAN DIEGO — Men with hypogonadism do not appear to have any increased risk for venous thrombotic events with exogenous testosterone replacement…
More Headlines »
morganatic-roan
morganatic-roan